Opportunity
Simpler Grants.gov #O-NIJ-2026-172784
NIJ funding to expand the Novel Psychoactive Substance Discovery, Education, and Reporting Institute
Buyer
National Institute of Justice
Posted
September 30, 2026
Respond By
October 07, 2026
Identifier
O-NIJ-2026-172784
NAICS
541715
The U.S. Department of Justice is seeking to expand an institute that identifies and reports emerging psychoactive substances. - Government buyer: U.S. Department of Justice, Office of Justice Programs, National Institute of Justice (NIJ). - Applicant: The Frederic Rieders Family Renaissance Foundation is identified as the invited applicant; the opportunity is restricted to the organization that received an official NIJ invitation. - Funding and award: Cooperative agreement of up to $1,000,000, with one anticipated award and no cost-sharing requirement. - Requested service: Enhance and operate the open-access Novel Psychoactive Substance Discovery, Education, and Reporting Institute (NPS Discovery) to rapidly identify and report emerging opioids, stimulants, and other potentially harmful or impairing drugs. - Conduct surveillance, sample testing, and research using forensic, clinical, and related samples and data; maintain an updated testing panel; and study new substances’ metabolism and pharmacology. - Develop confirmatory methods, transferable testing methodologies, analytical resources, and testing-scope recommendations; create a forensic drug database and data repository. - Share findings through reports, publications, webinars, conferences, toolkits, datasheets, and a stakeholder listserv; provide archived datasets and documentation and a final research paper. - OEMs and product vendors: None identified. No commercial products, part numbers, or product quantities are specified.
Description
This funding opportunity seeks to enhance the Novel Psychoactive Substance Discovery, Education, and Reporting Institute to rapidly identify and report newly emerging opioids, stimulants, and other drugs that may cause intoxication, impairment, or other adverse effects. Work includes developing an open-access drug early warning system, analytical resources and confirmatory testing methods, a forensically relevant drug database, and education and knowledge-transfer resources. The award is a cooperative agreement with a 36-month anticipated period beginning January 1, 2027, and up to $1,000,000 in funding. Applications are restricted to the applicant that received an official invitation letter from NIJ; the source names The Frederic Rieders Family Renaissance Foundation as the only accepted applicant.